Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Nature. 2010 Apr 1;464(7289):713–720. doi: 10.1038/nature08979

Table 2. Replicated CNV associations and those at replicated loci.

Only one of the several associated CNVs mapping to the HLA in the reference sequence is shown for each of RA, T1D and CD. Further details of replication assays and methods are given in the supplementary material. AC_000138.1_44 is a novel sequence insertion present in the Venter genome sequence but not in the reference sequence and hence no chromosomal location is presented. Fitted number of classes – the number of diploid copy-number classes. P-value - Combined Controls – the p value from the frequentist association test combining UKBS and 58C as controls. log10(BF) - Combined Controls – the log10 of the Bayes Factor from the Bayesian association analysis combining UKBS and 58C as controls. OR - Combined Controls – The odds ratio estimated for each additional copy of the CNV based on both UKBS and 58C as controls. Extended Reference refers to the analogous quantities calculated in comparing cases of the disease in question with UKBS, 58C, and aetiologically-unrelated cases. Control MAF – The minor allele frequency in controls (UKBS +58C). Case MAF – The minor allele frequency in cases. Minor allele frequency is only estimated for CNVs with 3 or fewer copy number classes.

Disease CNV Chromosome Start
(bp)
Length
(kb)
Locus Fitted
number
ofclasses
P-value
-Combined
Controls
P-value
-Extended
Reference
log10(BF)
-Combined
Controls
log10(BF)
-Extended
Reference
OR
-Combined
Controls
OR
-Extended
Reference
Control
MAF
Case
MAF
Replication:
cases /
controls
Replication
P value
T2D CNVR5583.1 12 69,818,942 1.0 TSPAN8 3 3.9E-05 2.5E-06 2.8 4.3 0.85 0.85 0.40 0.36 4549 / 5579# 3.9E-05
CD CNVR2646.1 5 150,157,836 3.9 IRGM 3 1.1E-07 5.5E-05 5.8 4.1 0.68 0.75 0.07 0.10 6894 / 7977# 7.5E-11
CD CNVR2647.1 5 150,183,562 20.1 IRGM 3 1.0E-07 4.3E-05 6.1 3.8 0.68 0.76 0.07 0.10 6894 / 7977# 3.9E-10
CD CNVR2841.20 6 31,416,574 5.1 HLA 3 1.7E-05 1.1E-05 3.6 3.9 0.80 0.82 0.19 0.23 NA NA
T1D CNVR2845.46 6 32,582,950 6.7 HLA 2 8.0E-153 2.1E-196 125.5 154.4 0.20 0.26 0.14 0.01 NA NA
RA CNVR2845.14 6 32,609,209 4.0 HLA 4 1.4E-39 8.1E-60 51.5 73.5 1.77 1.83 NA NA NA NA
RA CNVR1065.1 2⇒6 179,004,449 0.8 HLA 3 6.8E-49 1.6E-69 51.0 73.7 1.85 1.94 0.36 0.49 NA NA
T1D CNVR1065.1 2⇒6 179,004,449 0.8 HLA 3 1.3E-29 1.1E-39 28.0 38.4 1.62 1.61 0.36 0.47 NA NA
RA AC_000138.1
_44
NA NA 5.6 HLA 3 8.3E-04 1.1E-05 1.3 2.7 0.87 0.86 0.25 0.28 3398 / 2743 1.1E-03
T1D AC_000138.1
_44
NA NA 5.6 HLA 3 2.0E-31 2.7E-45 31.0 45.1 0.59 0.57 0.25 0.36 3883 / 2649 7.3E-50
CD CNVR7113.6 17 40,930,407 33.9 Chr17inv 3 1.2E-03 5.8E-04 1.4 1.6 1.15 1.14 0.24 0.21 4978 / 6069# 8.6E-05
T1D CNVR7113.6 17 40,930,407 33.9 Chr17inv 3 1.6E-03 7.5E-04 1.0 1.2 1.13 1.12 0.24 0.21 7911 / 9395# 4.6E-06
#

Replication sample includes WTCCC samples